Band 8b Principal Pharmacist Cancer Services BH CFH

Job summary

Principal Pharmacist - Cancer Services 8b Based at Barnet Hospital and Chase Farm Hospital

An exciting opportunity has become available for an experienced cancer pharmacist to lead the cancer pharmacy at the Royal Free London NHS Trust with the support of the newly created Clinical Lead Pharmacist Cancer role.

This post will be responsible for service based at Barnet Hospital and Chase Farm Hospital.

Additional funding has recently been secured to allow for expansion of the cancer pharmacy team to provide additional prescribing and monitoring of systemic anti-cancer therapy, primarily in the out-patient setting. The successful candidate will lead the team through this expansion, further developing the role of the pharmacist within the clinic setting and providing excellent patient care and outcomes within the cancer speciality. They will also be responsible for a large cancer pharmacy team and for delivering the safe and cost-effective use of systemic anti-cancer therapy (SACT)

The ideal candidate will be a highly experienced cancer pharmacist who is looking for the next step up to a leadership role with a proven track record in managing a team and a service. Experience of working in cancer clinics would also be beneficial.

Main duties of the job

JOB SUMMARY:

To lead and harmonise (with the support of the clinical lead pharmacist) the pharmacy cancer services team. Cancer services are provided across all Royal Free London site namely the royal free hospital, Barnet hospital, Finchley Memorial Hospital and Chase farm hospital. This post holder will have specific site responsibilities for Barnet Hospital and Chase Farm Hospitals.

To deliver, develop and evaluate clinical pharmacy services to the oncology, haematology, palliative care specialities in accordance with objectives set by the Clinical Lead Pharmacist, Cancer and the Deputy Chief Pharmacist.

Working closely with the multidisciplinary team, Service Line Leads and Divisional Managers, the post holder will develop initiatives and guidelines to ensure safe and cost-effective use of medicines and chemotherapy in this area, and across the interface between primary and secondary care.

The post holder will be jointly responsible for all aspects of the management of high cost drugs for cancer with the principal pharmacist based at RFH site, and the supply of medication via homecare where appropriate.

The post holder will be a key member of the Chemotherapy Operational Group (COG) jointly with the Principal Pharmacist Cancer Services based at the RFH and with the clinical lead pharmacist cancer.

About us

Our trust has around 10,000 staff serving 1.6 million patients. It comprises Barnet Hospital, Chase Farm Hospital, the Royal Free Hospital and more than 30 services in the community. This large scale organisation provides an unprecedented opportunity for us to continue our pioneering work, particularly in finding ways to deliver even better care to our patients. The Royal Free is one of the busiest Cancer Providers in England, receiving the sixth highest two-week wait referrals in England, the highest in London and over 50% of NCL referrals. The Trust also delivers the second highest volume of first cancer treatments in London with a cancer treatment growth of 20% over the last 3 years.

Everyone is welcome at Royal Free London NHS Foundation Trust. We're proud of our diversity and continue to undertake new initiatives to advance equality for all.

The Pharmacy department of the Royal Free London NHS Trust is a friendly, progressive, and expanding unit dedicated to providing the highest standards of pharmaceutical care and service in this large, internationally renowned teaching hospital. Quality improvement and cost-effective, safe use of medicines is at the forefront of everything we do. We have over 300 staff working across the 3 sites in all areas of pharmacy. The cancer pharmacy team are well established and play a critical role in the safe prescribing, manufacturing and monitoring of systemic anti-cancer therapy across all the sites.